Defects in the CDL biosynthetic pathways are associated with many mitochondrial dysfunctions and cardiac diseases, and alteration in the concentrations of CDL subtypes results in changes in the oxidative phosphorylation process, leading to cellular defects9. This evidence concerns the gene SGMS2 and heart disorder.